Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021

Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Asish Kumar Ghosh, Marco Kaiser, Md. Maruf Ahmed Molla, Tasnim Nafisa, Mahmuda Yeasmin, Rifat Hossain Ratul, Md. Mohiuddin Sharif, Arifa Akram, Nur Hosen, Rashid Mamunur, Md. Robed Amin, Alimul Islam, Md. Ehsanul Hoque, Olfert Landt, Simon D. Lytton
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/17549d5a261f44848d366cc37656030f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:17549d5a261f44848d366cc37656030f
record_format dspace
spelling oai:doaj.org-article:17549d5a261f44848d366cc37656030f2021-11-25T19:14:27ZMolecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 202110.3390/v131123101999-4915https://doaj.org/article/17549d5a261f44848d366cc37656030f2021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4915/13/11/2310https://doaj.org/toc/1999-4915Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of COVID-19 pandemic. To identify SARS CoV-2 variants in Bangladesh, patients who are RT-PCR-positive for COVID-19 infections in Dhaka were screened by a RT-PCR melting curve analysis for spike protein mutations. To assess the anti-SARS CoV-2 antibody responses, the levels of the anti-S -proteins IgA and IgG and the anti-N-protein IgG were measured by ELISA. Of a total of 36 RT-PCR positive samples (75%), 27 were identified as delta variants, with one carrying an additional Q677H mutation and two with single nucleotide substitutions at position 23029 (compared to Wuhan-Hu-1 reference NC 045512) in the genome sequence. Three (8.3%) were identified as beta variants, two (5.5%) were identified as alpha variants, three (8.3%) were identified as having a B.1.1.318 lineage, and one sample was identified as an eta variant (B.1.525) carrying an additional V687L mutation. The trend of higher viral load (lower Cp values) among delta variants than in the alpha and beta variants was of borderline statistical significance (<i>p</i> = 0.045). Prospective studies with larger Bangladeshi cohorts are warranted to confirm the emergence of S-protein mutations and their association with antibody response in natural infection and potential breakthrough in vaccinated subjects.Asish Kumar GhoshMarco KaiserMd. Maruf Ahmed MollaTasnim NafisaMahmuda YeasminRifat Hossain RatulMd. Mohiuddin SharifArifa AkramNur HosenRashid MamunurMd. Robed AminAlimul IslamMd. Ehsanul HoqueOlfert LandtSimon D. LyttonMDPI AGarticleSARS-CoV-2delta variantBangladeshanti-S-protein IgGanti-N-protein IgGamino acid mutationsMicrobiologyQR1-502ENViruses, Vol 13, Iss 2310, p 2310 (2021)
institution DOAJ
collection DOAJ
language EN
topic SARS-CoV-2
delta variant
Bangladesh
anti-S-protein IgG
anti-N-protein IgG
amino acid mutations
Microbiology
QR1-502
spellingShingle SARS-CoV-2
delta variant
Bangladesh
anti-S-protein IgG
anti-N-protein IgG
amino acid mutations
Microbiology
QR1-502
Asish Kumar Ghosh
Marco Kaiser
Md. Maruf Ahmed Molla
Tasnim Nafisa
Mahmuda Yeasmin
Rifat Hossain Ratul
Md. Mohiuddin Sharif
Arifa Akram
Nur Hosen
Rashid Mamunur
Md. Robed Amin
Alimul Islam
Md. Ehsanul Hoque
Olfert Landt
Simon D. Lytton
Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
description Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of COVID-19 pandemic. To identify SARS CoV-2 variants in Bangladesh, patients who are RT-PCR-positive for COVID-19 infections in Dhaka were screened by a RT-PCR melting curve analysis for spike protein mutations. To assess the anti-SARS CoV-2 antibody responses, the levels of the anti-S -proteins IgA and IgG and the anti-N-protein IgG were measured by ELISA. Of a total of 36 RT-PCR positive samples (75%), 27 were identified as delta variants, with one carrying an additional Q677H mutation and two with single nucleotide substitutions at position 23029 (compared to Wuhan-Hu-1 reference NC 045512) in the genome sequence. Three (8.3%) were identified as beta variants, two (5.5%) were identified as alpha variants, three (8.3%) were identified as having a B.1.1.318 lineage, and one sample was identified as an eta variant (B.1.525) carrying an additional V687L mutation. The trend of higher viral load (lower Cp values) among delta variants than in the alpha and beta variants was of borderline statistical significance (<i>p</i> = 0.045). Prospective studies with larger Bangladeshi cohorts are warranted to confirm the emergence of S-protein mutations and their association with antibody response in natural infection and potential breakthrough in vaccinated subjects.
format article
author Asish Kumar Ghosh
Marco Kaiser
Md. Maruf Ahmed Molla
Tasnim Nafisa
Mahmuda Yeasmin
Rifat Hossain Ratul
Md. Mohiuddin Sharif
Arifa Akram
Nur Hosen
Rashid Mamunur
Md. Robed Amin
Alimul Islam
Md. Ehsanul Hoque
Olfert Landt
Simon D. Lytton
author_facet Asish Kumar Ghosh
Marco Kaiser
Md. Maruf Ahmed Molla
Tasnim Nafisa
Mahmuda Yeasmin
Rifat Hossain Ratul
Md. Mohiuddin Sharif
Arifa Akram
Nur Hosen
Rashid Mamunur
Md. Robed Amin
Alimul Islam
Md. Ehsanul Hoque
Olfert Landt
Simon D. Lytton
author_sort Asish Kumar Ghosh
title Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
title_short Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
title_full Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
title_fullStr Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
title_full_unstemmed Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
title_sort molecular and serological characterization of the sars-cov-2 delta variant in bangladesh in 2021
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/17549d5a261f44848d366cc37656030f
work_keys_str_mv AT asishkumarghosh molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT marcokaiser molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT mdmarufahmedmolla molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT tasnimnafisa molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT mahmudayeasmin molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT rifathossainratul molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT mdmohiuddinsharif molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT arifaakram molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT nurhosen molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT rashidmamunur molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT mdrobedamin molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT alimulislam molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT mdehsanulhoque molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT olfertlandt molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
AT simondlytton molecularandserologicalcharacterizationofthesarscov2deltavariantinbangladeshin2021
_version_ 1718410076199321600